tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Fuso Pharmaceutical Announces Executive Officer Changes

Story Highlights
Fuso Pharmaceutical Announces Executive Officer Changes

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Fuso Pharmaceutical Industries,Ltd. ( (JP:4538) ) just unveiled an announcement.

Fuso Pharmaceutical Industries, Ltd. announced changes in its executive officer positions, effective September 1, 2025, following a Board of Directors meeting. These personnel changes involve reassignments within the company’s production division, impacting the management of its Ibaraki and Okayama factories, which may influence operational efficiencies and strategic positioning in the industry.

More about Fuso Pharmaceutical Industries,Ltd.

Fuso Pharmaceutical Industries, Ltd. operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products. The company is listed on the Tokyo Stock Exchange Prime Market and is led by President and Representative Director Mikio Toda.

Average Trading Volume: 17,159

Technical Sentiment Signal: Buy

Current Market Cap: Yen19.39B

See more data about 4538 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1